Select a bright flashing yellow LED or an audible alarm Counts time elapsed after the alarm N.I.S.T. traceable certificate of compliance available: 1225A36, 1225A38 and 1225A40
Select a bright flashing yellow LED or an audible alarm Counts time elapsed after the alarm N.I.S.T. traceable certificate of compliance available: 1225A36, 1225A38 and 1225A40
146760 Highly absorbent pad ideal for removal of all kinds of water based spills from hard floors Ultra-thin construction moved excess liquid quickly to absorbent core Water impermeable polyethylene on back side for hygienic removal after use High co
146760 Highly absorbent pad ideal for removal of all kinds of water based spills from hard floors Ultra-thin construction moved excess liquid quickly to absorbent core Water impermeable polyethylene on back side for hygienic removal after use High co
T-2307, an arylamidine, has antifungal activities in vitro and in vivo. T-2307 exhibits broad-spectrum activity against clinically significant pathogens, including Candida species (MIC range, 0.00025 to 0.0078 μg/ml), Cryptococcus neoformans (MIC
T-2307, an arylamidine, has antifungal activities in vitro and in vivo. T-2307 exhibits broad-spectrum activity against clinically significant pathogens, including Candida species (MIC range, 0.00025 to 0.0078 μg/ml), Cryptococcus neoformans (MIC
TAS-114 is an orally active dual dUTPase/dihydropyrimidine dehydrogenase (DPD) inhibitor, can improving the therapeutic efficacy of fluoropyrimidineIn VitroTAS-114 (1-10 μM: 72 hours) increases the cytotoxicity of 5-Fluorouracil (5-FU) and
TAS-114 is an orally active dual dUTPase/dihydropyrimidine dehydrogenase (DPD) inhibitor, can improving the therapeutic efficacy of fluoropyrimidineIn VitroTAS-114 (1-10 μM: 72 hours) increases the cytotoxicity of 5-Fluorouracil (5-FU) and
T-2307, an arylamidine, has antifungal activities in vitro and in vivo. T-2307 exhibits broad-spectrum activity against clinically significant pathogens, including Candida species (MIC range, 0.00025 to 0.0078 μg/ml), Cryptococcus neoformans (MIC
T-2307, an arylamidine, has antifungal activities in vitro and in vivo. T-2307 exhibits broad-spectrum activity against clinically significant pathogens, including Candida species (MIC range, 0.00025 to 0.0078 μg/ml), Cryptococcus neoformans (MIC
T-2307, an arylamidine, has antifungal activities in vitro and in vivo. T-2307 exhibits broad-spectrum activity against clinically significant pathogens, including Candida species (MIC range, 0.00025 to 0.0078 μg/ml), Cryptococcus neoformans (MIC
T-2307, an arylamidine, has antifungal activities in vitro and in vivo. T-2307 exhibits broad-spectrum activity against clinically significant pathogens, including Candida species (MIC range, 0.00025 to 0.0078 μg/ml), Cryptococcus neoformans (MIC
T-2307, an arylamidine, has antifungal activities in vitro and in vivo. T-2307 exhibits broad-spectrum activity against clinically significant pathogens, including Candida species (MIC range, 0.00025 to 0.0078 μg/ml), Cryptococcus neoformans (MIC
T-2307, an arylamidine, has antifungal activities in vitro and in vivo. T-2307 exhibits broad-spectrum activity against clinically significant pathogens, including Candida species (MIC range, 0.00025 to 0.0078 μg/ml), Cryptococcus neoformans (MIC